Duchenne muscular dystrophy
Clinical research in Duchenne muscular dystrophy focuses on muscle disease affecting strength and mobility, with attention to restoring dystrophin expression in skeletal muscle tissue.
- Muscle function
- Dystrophin protein
- Skeletal muscle involvement
These studies examine therapeutic interest in progressive neuromuscular impairment and the biological markers linked to muscle integrity.
Myotonic dystrophy type 1
Research in myotonic dystrophy type 1 centers on inherited neuromuscular disorder symptoms, including hand myotonia and broader functional limitations.
- Hand myotonia
- Muscle function
- Neuromuscular symptoms
The therapeutic focus includes assessment of changes in muscle performance and disease-related motor impairment.
Neuromuscular therapeutics
The sponsor’s portfolio reflects a concentrated interest in neuromuscular therapeutics, with programs directed toward inherited muscle disorders and their functional consequences.
- Inherited muscle disease
- Motor function
- Muscle pathology
Research activity includes evaluation of clinically relevant outcomes tied to muscle performance and disease burden.
Muscle tissue biomarkers
Investigations also emphasize muscle tissue biomarkers used to track biological response in neuromuscular disease, including measures associated with protein expression and tissue-level change.
- Protein expression
- Tissue-level response
- Biological markers
This area aligns with research into measurable indicators of treatment effect in chronic muscle disorders.
